Moreover, placebo-controlled, randomized clinical trials could be carried out to determine if thyroid hormones or their analogs can effectively mitigate the fatty liver changes in NAFLD and prevent its progression. Here, TG is linked to metabolic dysfunction-associated steatotic liver disease.